Thus, our study underscores the contribution of peripheral inflammation to the loss of dopaminergic neurons in PD model mice and identifies monocyte TREM-1 as a new factor in the pathophysiology of PD, which may constitute a novel systemic therapy for PD patients. The gene discussed is TREM1; the disease is Parkinson disease.